| request information: |
|
| name: | Fas Ligand, soluble human |
| cat_no: | S8689 |
| gene id: | human FASLG(356) |
| brand: | SIGMA |
| prod_type: | Chemical |
| name_suffix: | recombinant, expressed in HEK 293 cells, lyophilized powder |
| storage temp.: | -20C |
| storage: | -20C |
| form: | lyophilized powder |
| syns: | SuperFas Ligand(TM) |
| unspsc_code: | 12352202 |
| mdl_no: | MFCD01092558 |
| legal information: | SuperFas Ligand is a trademark of Alexis Biochemicals Corp. |
| application: | Exerts its biological activity at a concentration range of 1-5 ng/ml on A20B lymphoma cells. Does not require any enhancer, as the modified linker sequence already facilitates the formation of active FasL complexes. rhsSuperFasL(TM) recognizes its receptor Fas (CD95) of the following species: human, rat, mouse. |
| mol wt: | mol wt 32 kDa by SDS-PAGE (nonglycosylated form, under reducing conditions); mol wt 35 kDa by SDS-PAGE (glycosylated form, under reducing conditions) |
| biochem/physiol actions: | Fas ligand, a protein belonging to the tumor necrosis factor (TNF) family of cytokines, induces apoptosis in cells expressing the cell membrane receptor Fas (CD95/Apo-1). |
order or
more information: | company product webpage |